Colin Hislop is Chief Medical Officer at Anthera Pharmaceuticals Inc (ANTH). They have made 5 open-market trades across 2 companies since 2010, most recently 2017-10-19.
CIK 0001314902
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $2K since 2010, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VSAR | SELL | 2017-10-19 | 2017-10-23 | $2.55 | $2K | -32.1% | -30.2% | -18.9% |
| VSAR | SELL | 2017-04-04 | 2017-04-05 | $21.20 | $742K | -4.6% | -15.3% | -17.5% |
| ANTH | SELL · 10b5-1 | 2015-11-13 | 2015-11-18 | $5.31 | $66K | N/A | N/A | N/A |
| ANTH | SELL | 2015-11-11 | 2015-11-12 | $5.38 | $27K | N/A | N/A | N/A |
| ANTH | SELL · 10b5-1 | 2012-02-03 | 2012-02-06 | $8.20 | $246K | N/A | N/A | N/A |
| ANTH | SELL | 2011-11-08 | 2011-11-10 | $6.74 | $101K | N/A | N/A | N/A |
| ANTH | BUY | 2010-08-18 | 2010-08-20 | $4.80 | $2K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.